Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Roivant Sciences Ltd. Insider Profile
4 Followers
Roivant Sciences Ltd., Ten Percent Owner at Arbutus Biopharma, holds 79.81M shares in Immunovant (Ticker: IMVT), holds 18.58M shares in Sio Gene Therapies (Ticker: SIOX), holds 0.00 shares in Myovant Sciences (Ticker: MYOV).
Roivant Sciences Ltd. Arbutus Biopharma (ABUS)Ten Percent Owner
Arbutus Biopharma (ABUS)
Ten Percent Owner
Ranked #13,993 out of 97,997 Corporate Insiders
Profitable Transactions
9 out of 18 Profitable Transactions
Average Return
+7.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Roivant Sciences Ltd. holds in companies
Most Profitable Insider Trade
The most profitable trade made by Roivant Sciences Ltd.
Roivant Sciences Ltd.'s Trading History
Arbutus Biopharma
Mar 16, 2015
Ten Percent Owner
Informative Buy
―
$143.35M
Myovant Sciences
Dec 31, 2019
―
Uninformative Sell
―
$0.00
Sio Gene Therapies
Feb 27, 2020
―
Informative Buy
20.00M
$8.88M
Urovant Sciences
Dec 31, 2019
―
Uninformative Sell
―
$0.00
Immunovant
Oct 04, 2023
Director, Ten Percent Owner
Uninformative Buy
170.00M
$2.23B
List of latest transactions for each holding click on a transaction to see Roivant Sciences Ltd.'s performance on stock
You May Also Like
Roivant Sciences Ltd. insider profile FAQ
What is the percentage of profitable transactions made by Roivant Sciences Ltd.?
The percentage of profitable transactions made by Roivant Sciences Ltd. is 50%.
What is the average return per transaction made by Roivant Sciences Ltd.?
The average return per transaction made by Roivant Sciences Ltd. is 7.50%.
What stocks does Roivant Sciences Ltd. hold?
Roivant Sciences Ltd. holds: ABUS, MYOV, SIOX, UROV, IMVT stocks.
What was Roivant Sciences Ltd.’s latest transaction?
Roivant Sciences Ltd. latest transaction was an Uninformative Buy of $170.00M.
What was Roivant Sciences Ltd.'s most profitable transaction?
Roivant Sciences Ltd.’s most profitable transaction was an Informative Buy of IMVT stock on October 7, 2022. The return on the trade was 298.50%.
What is Roivant Sciences Ltd.'s role in Arbutus Biopharma?
Roivant Sciences Ltd.'s role in Arbutus Biopharma is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.